fax: 858-822-0084
Liver Failure/Cirrhosis/Portal Hypertension
Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent†‡
Article first published online: 4 DEC 2012
DOI: 10.1002/hep.25938
Copyright © 2012 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., Page, P. and Brenner, D. A. (2012), Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology, 56: 2316–2327. doi: 10.1002/hep.25938
- †
Potential conflict of interest: B.L., F.G., L.F.-C., S.M., F.H., C.M., C.S., and P.P. are employees of GenKyoTex SA, which developed and provided the drug (GKT137831) used in this study.
- ‡
This work was supported by the American Liver Foundation (grant nos.: 1 R24 DK090962, 5 P50 AA011999, and 5 R01 GM041804).
- §
fax: 858-822-0084
Publication History
- Issue published online: 4 DEC 2012
- Article first published online: 4 DEC 2012
- Accepted manuscript online: 14 JUL 2012 03:10AM EST
- Manuscript Accepted: 13 JUN 2012
- Manuscript Received: 11 JAN 2012
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
